Rein Therapeutics (RNTX) Proxy filing summary

Executive summary

• Annual meeting scheduled for July 20, 2026, to be held online at 9:00 AM ET.

• Proxy materials and annual report are available online for review and voting.

• Shareholders are encouraged to vote electronically and can opt for electronic delivery of future materials.

Voting matters and shareholder proposals

• Election of two Class III directors: Reinhard J. Ambros, Ph.D., and Josef H. von Rickenbach.

• Proposal to increase authorized shares of common stock.

• Ratification of CBIZ CPAs P.C. as independent registered public accounting firm.

• Advisory vote to approve named executive officer compensation.

Board of directors and corporate governance

• Board recommends voting FOR all director nominees and proposals listed.